{{Rsnum
|rsid=4845378
|Gene=CHRNB2
|Chromosome=1
|position=154572175
|Orientation=plus
|GMAF=0.1061
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CHRNB2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19482438
|Title=Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence
}}

{{PMID|18813964|OA=1
}} Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

{{PMID|18830724|OA=1
}} Assessment of Alzheimer's disease case-control associations using family-based methods.

{{PMID|20574532|OA=1
}} Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

{{on chip | 23andMe v2}}